|
|
Volumn 9, Issue SUPPL. 2, 2002, Pages
|
|
The first phase I study of a novel ultrasound contrast agent (BR14): Assessment of safety and efficacy in liver and kidneys
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BR 14;
CONTRAST MEDIUM;
UNCLASSIFIED DRUG;
BR14 CONTRAST AGENT;
FLUOROCARBON;
MICROSPHERE;
PERFLUOROBUTANE;
PHOSPHOLIPID;
ADULT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
KIDNEY;
LABORATORY DIAGNOSIS;
LIVER;
MALE;
NORMAL HUMAN;
PHASE 1 CLINICAL TRIAL;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
ULTRASOUND;
ARTICLE;
ECHOGRAPHY;
INTRAVENOUS DRUG ADMINISTRATION;
ADULT;
CONTRAST MEDIA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FLUOROCARBONS;
HUMANS;
INFUSIONS, INTRAVENOUS;
KIDNEY;
LIVER;
MALE;
MICROSPHERES;
PHOSPHOLIPIDS;
|
|
EID: 0036337737
PISSN: 10766332
EISSN: None
Source Type: Journal
DOI: 10.1016/S1076-6332(03)80237-4 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (3)
|
